Back to Search
CAITLIN TIMMERS, MD
MD
Obstetrics & Gynecology Physician
NPI: 1669963799IndividualAccepts Medicare
Specialties, Licenses & Credentials
Obstetrics & Gynecology PhysicianPrimary
Obstetrics & Gynecology
Code: 207V00000X
81013-20(WI)
CMS Specialties
PrimaryOBSTETRICS/GYNECOLOGY
Education
UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE
Class of 2018
Research & Publications (20)
Discovery of selective luteinizing hormone receptor agonists using the bivalent ligand method.
PMID 19475639·ChemMedChem·2009
8-other
Induction of ovulation by a potent, orally active, low molecular weight agonist (Org 43553) of the luteinizing hormone receptor.
PMID 19088107·Hum Reprod·2009
7-preclinical
A signaling-selective, nanomolar potent allosteric low molecular weight agonist for the human luteinizing hormone receptor.
PMID 18551279·Naunyn Schmiedebergs Arch Pharmacol·2008
4-observational
Synthesis and evaluation of homodimeric GnRHR antagonists having a rigid bis-propargylated benzene core.
PMID 18282756·Bioorg Med Chem·2008
7-preclinical
[3H]Org 43553, the first low-molecular-weight agonistic and allosteric radioligand for the human luteinizing hormone receptor.
PMID 17989351·Mol Pharmacol·2008
4-observational
Identification of an altered peptide ligand based on the endogenously presented, rheumatoid arthritis-associated, human cartilage glycoprotein-39(263-275) epitope: an MHC anchor variant peptide for immune modulation.
PMID 17645792·Arthritis Res Ther·2007
7-preclinical
Synthesis and evaluation of homo-bivalent GnRHR ligands.
PMID 17517510·Bioorg Med Chem·2007
7-preclinical
E2f1, E2f2, and E2f3 control E2F target expression and cellular proliferation via a p53-dependent negative feedback loop.
PMID 17167174·Mol Cell Biol·2007
7-preclinical
Control of the p53-p21CIP1 Axis by E2f1, E2f2, and E2f3 is essential for G1/S progression and cellular transformation.
PMID 17008321·J Biol Chem·2006
7-preclinical
Identification of substituted 6-amino-4-phenyltetrahydroquinoline derivatives: potent antagonists for the follicle-stimulating hormone receptor.
PMID 15771412·J Med Chem·2005
7-preclinical
Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferation.
PMID 15722552·J Biol Chem·2005
7-preclinical
Bone morphogenetic protein 3B silencing in non-small-cell lung cancer.
PMID 15116090·Oncogene·2004
8-other
Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation.
PMID 12893818·J Biol Chem·2003
7-preclinical
Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice.
PMID 12893777·Genes Dev·2003
7-preclinical
Inactivation of E2F3 results in centrosome amplification.
PMID 12726860·Cancer Cell·2003
7-preclinical
The first orally active low molecular weight agonists for the LH receptor: thienopyr(im)idines with therapeutic potential for ovulation induction.
PMID 12362369·Chembiochem·2002
7-preclinical
Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb.
PMID 12065245·Cell Growth Differ·2002
7-preclinical
The E2F1-3 transcription factors are essential for cellular proliferation.
PMID 11719808·Nature·2001
7-preclinical
Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.
PMID 11239454·Mol Cell·2001
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1000 N OAK AVE
MARSHFIELD, WI 54449 - Phone
- (715) 387-5511
Quick Facts
- NPI
- 1669963799
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 8
- Publications
- 20
Are you this provider?
Claim Your Profile